Armis Biopharma is a biopharmaceutical company with a growing pipeline of non-systemic.
Armis Biopharma is a biopharmaceutical company with a growing pipeline of non-systemic, non-resistant anti-infective therapeutics designed to address antibiotic resistance and healthcare-associated infections, a serious and rapidly growing phenomenon.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 9, 2020 | Grant | $423.04K | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Institutes of Health (NIH) | — | Grant |